LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Zoetis Inc

Gesloten

SectorGezondheidszorg

121.51 -0.44

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

118.21

Max

122.13

Belangrijke statistieken

By Trading Economics

Inkomsten

-118M

603M

Verkoop

-13M

2.4B

K/W

Sectorgemiddelde

21.422

66.845

Dividendrendement

1.53

Winstmarge

25.262

Werknemers

14,500

EBITDA

-122M

947M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+19.28% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.53%

2.25%

Volgende Winsten

5 mei 2026

Volgende dividenddatum

2 jun 2026

Volgende Ex Dividend datum

20 apr 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

415M

57B

Vorige openingsprijs

121.95

Vorige sluitingsprijs

121.51

Nieuwssentiment

By Acuity

41%

59%

127 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Zoetis Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 aug 2025, 11:06 UTC

Winsten

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5 aug 2025, 11:06 UTC

Winsten

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5 aug 2025, 11:05 UTC

Winsten

Zoetis 2Q Adj EPS $1.76 >ZTS

6 mei 2025, 11:14 UTC

Winsten

Zoetis Sees FY25 Adj EPS $6.20-Adj EPS $6.30 >ZTS

6 mei 2025, 11:14 UTC

Winsten

Zoetis Sees FY25 Rev $9.43B-$9.58B >ZTS

6 mei 2025, 11:13 UTC

Winsten

Zoetis 1Q Adj EPS $1.48 >ZTS

6 mei 2025, 11:00 UTC

Winsten

Zoetis 1Q Net $631M >ZTS

6 mei 2025, 11:00 UTC

Winsten

Zoetis 1Q Rev $2.22B >ZTS

6 mei 2025, 11:00 UTC

Winsten

Zoetis 1Q EPS $1.41 >ZTS

Peer Vergelijking

Prijswijziging

Zoetis Inc Prognose

Koersdoel

By TipRanks

19.28% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 145.8 USD  19.28%

Hoogste 190 USD

Laagste 130 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zoetis Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

5

Buy

6

Hold

0

Sell

Technische score

By Trading Central

152.58 / N/ASteun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

127 / 351 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat